Related Experiment Video

Updated: Jun 17, 2026

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease
08:51

Application of Unsupervised Multi-Omic Factor Analysis to Uncover Patterns of Variation and Molecular Processes Linked to Cardiovascular Disease

Published on: September 20, 2024

Genomics of cardiovascular disease

Leslie Cole Manace1, Tapan N Godiwala, Mark W Babyatsky

  • 1Department of Genetics, Kaiser Oakland Medical Center, Oakland, CA, USA. leslie.c.manace@kp.org

The Mount Sinai Journal of Medicine, New York
|December 17, 2009
PubMed

Insights

Cardiovascular disease research leverages genetic insights from monogenic syndromes and genome-wide studies to identify predisposition markers. This genomic data, combined with biomarkers, advances personalized medicine for tailored cardiovascular care.

Area of Science:

  • Cardiovascular disease research
  • Genomics and personalized medicine

Background:

  • Cardiovascular disease is a leading global cause of death and disability.
  • Monogenic syndromes offer insights into cardiovascular disease pathophysiology.
  • Genomic research is expanding understanding of cardiovascular disorders.

Purpose of the Study:

  • To explore the role of genomic research in understanding cardiovascular disease.
  • To highlight the potential of personalized medicine in cardiovascular care.

Main Methods:

  • Review of post-Human Genome Project resources and technologies.
  • Analysis of genome-wide predisposition markers, pharmacogenetics, and genomic signatures.
  • Integration of genetic information with other biomarkers.

Main Results:

  • Elucidation of known gene impacts on cardiovascular disease development and progression.
  • Discovery of novel genomic regions associated with cardiovascular outcomes.
  • Advancement towards personalized preventive and therapeutic strategies.

Conclusions:

  • Genomic research significantly enhances the understanding of cardiovascular disease.
  • Personalized medicine, integrating genetic data, promises improved patient outcomes and reduced adverse events.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...